Literature DB >> 306804

Prevalence of depression over a 12-month period in a nonpatient population.

J Barrett, M W Hurst, C DiScala, R M Rose.   

Abstract

A nonpatient population of air traffic controllers, all of whom remained employed during the observation period, was examined monthly for one year for level of depression using the Zung Self-Rating Depression Scale. The average monthly prevalence of depression was 9.1%, with 7.0% at the symptom level, 1.9% at a level comparable to outpatients, and 0.2% with moderately severe levels. These figures were generally similar to those for other reported population groups, although exact comparisons were difficult because of the preselection for health in this population. Two patterns of depression were observed. One was characterized by an acute, episodic symptomatology returning to nonsymptomatic levels for most of the year, similar to Research Diagnostic Criteria (RDC) category "episodic minor depressive disorder." The other showed a chronic, fluctuating course with significant depressive symptomatology over half the year, similar to RDC category "chronic and intermittent minor depressive disorder."

Entities:  

Mesh:

Year:  1978        PMID: 306804     DOI: 10.1001/archpsyc.1978.01770300083009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  12 in total

1.  Condition of depressive symptoms among Japanese dental students.

Authors:  Yasuko Takayama; Eiji Miura; Kazue Miura; Shigeru Ono; Chikahiro Ohkubo
Journal:  Odontology       Date:  2011-05-07       Impact factor: 2.634

2.  The effects of lifestyle and type a behavior on the life-stress process.

Authors:  S Maruyama; K Morimoto
Journal:  Environ Health Prev Med       Date:  1997-04       Impact factor: 3.674

3.  Symptomatology of depressive state in the workplace. A 20-year cohort study.

Authors:  Takeaki Takeuchi; Mutsuhiro Nakao; Eiji Yano
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

4.  The effect of level of depression on the use of visual analogue scales by normal volunteers.

Authors:  M Peet; S Ellis; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

5.  Usefulness of five-item and three-item Mental Health Inventories to screen for depressive symptoms in the general population of Japan.

Authors:  Shin Yamazaki; Shunichi Fukuhara; Joseph Green
Journal:  Health Qual Life Outcomes       Date:  2005-08-08       Impact factor: 3.186

6.  Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study.

Authors:  Haruki Momma; Kaijun Niu; Yoritoshi Kobayashi; Cong Huang; Masahiko Chujo; Atsushi Otomo; Hiroko Tadaura; Toshio Miyata; Ryoichi Nagatomi
Journal:  Diabetol Metab Syndr       Date:  2014-03-06       Impact factor: 3.320

7.  Irritable bowel syndrome is positively related to metabolic syndrome: a population-based cross-sectional study.

Authors:  Yinting Guo; Kaijun Niu; Haruki Momma; Yoritoshi Kobayashi; Masahiko Chujo; Atsushi Otomo; Shin Fukudo; Ryoichi Nagatomi
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

8.  Relationship between daily isoflavone intake and sleep in Japanese adults: a cross-sectional study.

Authors:  Yufei Cui; Kaijun Niu; Cong Huang; Haruki Momma; Lei Guan; Yoritoshi Kobayashi; Hui Guo; Masahiko Chujo; Atsushi Otomo; Ryoichi Nagatomi
Journal:  Nutr J       Date:  2015-12-29       Impact factor: 3.271

9.  Regional homogeneity abnormalities affected by depressive symptoms in migraine patients without aura: a resting state study.

Authors:  Dahua Yu; Kai Yuan; Ling Zhao; Fanrong Liang; Wei Qin
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

10.  Student centered curricular elements are associated with a healthier educational environment and lower depressive symptoms in medical students.

Authors:  Eiad Abdelmohsen AlFaris; Naghma Naeem; Farhana Irfan; Riaz Qureshi; Cees van der Vleuten
Journal:  BMC Med Educ       Date:  2014-09-17       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.